SIGN UP AND
SAVE 5%
Inositol (MYO-DCI 40/1)
A natural compound that plays a central role in cell signalling and insulin sensitivity. It has beenwidely studied for its benefits in the management of PCOS, with research indicating its ability to improveovarian function, restore menstrual regularity and reduce hyperandrogenism1. Studies also showits role in improving fertility by supporting oocyte quality and follicular development1.
An isomer of myo-inositol, D-chiro-inositol complements its counterpart by improving insulin sensitivity andreducing systemic inflammation2. When used in a physiological ratio with myo-inositol, it has shown synergistic effects on metabolic and hormonal profiles, particularly in women with PCOS or insulin resistance.
N-acetyl-L-cysteine (NAC)
Chromium (chromium (III) picolinate) and vanadium (vanadium chelate product PVH)
Chromium plays a crucial role in improving glucose metabolism and insulin signalling4. Clinical trials have demonstrated its effectiveness in reducing insulin resistance and stimulating ovulation, making it particularly beneficial for women with PCOS5.
Vanadium is an insulin-mimetic and anti-diabetic compound that has been studied for its role in regulating glucose and lipid metabolism6. Emerging evidence suggests that vanadium can mimic some of the actions of insulin, promoting better glycemic control in individuals with insulin resistance.
VISIT OUR HEALTH RESOURCES SECTION TO LEARN MORE ABOUT THESE SPECIFIC INGREDIENTS
Why choose Inosia?
Inosia is a scientifically formulated supplement designed to treat hormonal imbalances and associated symptoms. Inosia harnesses the synergistic effects of clinically tested ingredients to support menstrual cycle regularity, relieve premenstrual discomfort and reduce the symptoms of menopause, including hot flashes. Its carefully selected components work together to promote optimal hormonal health while addressing underlying metabolic concerns
PCOS is the most common endocrine disorder in women. It affects between 6% and 18% of women of reproductive age. In addition to the characteristic ovulatory dysfunctions, PCOS is most often accompanied by hirsutism, metabolic disorders (insulin resistance, type-2 diabetes, overweight, hypertension and hyperlipidemia), chronic inflammation, and menstrual irregularity.
How do I take my treatment?
Take 2 capsules 2 times a day.
How long should I take Inosia?
We recommend a course of treatment lasting 3 to 6 months, renewable if necessary.
We encourage our patients to take a course of treatment lasting at least 3 months, in order to observe profound changes and give the body time to find a new equilibrium.
It is ideal to start treatment 3 to 6 months before fertility treatments.
When to stop taking Inosia
Inosia should be stopped as soon as pregnancy is confirmed.
Consult a health care practitioner prior to use if you have a liver disorder,diabetes, or are taking hormone-containing medications (e.g. progesterone preparations, oral contraceptives, hormone replacement therapy), or if your symptomspersist or worsen. Discontinue use and consult a health care practitioner if youdevelop symptoms of liver disease.
Do not use this product if you are pregnant or breast-feeding, if you are takingthiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or otherdrugs that may aggravate an electrolyte imbalance, or if you have hypokalemia, high blood pressure or a kidney or cardiovascular disorder. Avoid use if you are taking antibiotics or nitroglycerin.
- Genazzani AD. Inositol as putative integrative treatment for PCOS. Reprod Biomed Online. Dec 2016;33(6):770-780. doi:10.1016/j.rbmo.2016.08.024.
- Montt-Guevara MM, Finiguerra M, Marzi I, et al. D-Chiro-Inositol Regulates Insulin Signaling in
Human Adipocytes. Front Endocrinol (Lausanne). 2021;12:660815.
doi:10.3389/fendo.2021.660815. - Fulghesu, A. M. et al. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril 77, 1128-1135 (2002).
- Havel PJ. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:2-14.
- Ashoush S, Abou-Gamrah A, Bayoumy H, Othman N. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial. J Obstet Gynaecol Res. Mar 2016;42(3):279-85. doi:10.1111/jog.12907.
- Srivastava AK, Mehdi MZ. Insulino-mimetic and anti-diabetic effects of vanadium compounds. Diabet Med. Jan 2005;22(1):2-13. doi:10.1111/j.1464-5491.2004.01381.x.